Women with atrial fibrillation in the Middle East: utilization of oral anticoagulant agents in a population with bad baseline clinical profiles and risk scores

Autor:	H Shawar, Rasheed K. Ibdah, A Hammoudeh, Abdullah Al-kasasbeh, A Ababneh, Sukaina I. Rawashdeh
Rok vydání:	2021
Předmět:	medicine.medical_specialty education.field_of_study business.industry Internal medicine Population medicine Oral anticoagulant Atrial fibrillation Cardiology and Cardiovascular Medicine medicine.disease Baseline (configuration management) education business
Zdroj:	European Heart Journal. 42
ISSN:	1522-9645 0195-668X
DOI:	10.1093/eurheartj/ehab724.2773
Popis:	Background Atrial fibrillation (AF) is the most common sustained arrhythmia in women and men worldwide and in the Middle East. Several studies have shown that women with AF are undertreated despite worse baseline clinical and risk profiles compared with men. It is largely unknown if this also applies to Middle Eastern AF patients. Purpose To evaluate baseline clinical features and utilization of guideline-recommended oral anticoagulant medications (OACs) in Middle Eastern women with AF. Methods The Jordan AF prospective multicenter study enrolled 2160 patients with AF, including 1164 (53.9%) women, in 20 hospital and outpatient clinics (May 2019 through January 2021). Results Nonvalvular AF was present in 1038 (91.0%) of women and 935 (94.6%) of men. Compared with men, women were older (mean age 69.2±11.5 years vs. 66.1±14.9 years, p Conclusions Middle Eastern women with AF have worse baseline clinical and risk score profiles compared with men. In disagreement with other regional studies, the majority of these women received guideline-recommended OACs. Funding Acknowledgement Type of funding sources: None.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::d5c8b520472a42b8296fd58aea9c8215 https://doi.org/10.1093/eurheartj/ehab724.2773 Zobrazit plný text záznamu